New Zealand markets closed

Sera Prognostics, Inc. (SERA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.92-0.54 (-5.71%)
As of 11:25AM EDT. Market open.

Sera Prognostics, Inc.

2749 East Parleys Way
Suite 200
Salt Lake City, UT 84109
United States
801 990 0520
https://seraprognostics.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees55

Key executives

NameTitlePayExercisedYear born
Ms. Evguenia Lindgardt M.B.A.President, CEO & Director37.5kN/A1974
Dr. Gregory C. Critchfield M.D., M.S.Executive Director790.74kN/A1953
Dr. Steven W. GravesCo-Founder and Co-Chairman of The Scientific Advisory BoardN/AN/AN/A
Dr. M. Sean Esplin M.D.Co-Founder and Co-Chairman of Scientific Advisory BoardN/AN/AN/A
Mr. Austin AertsChief Financial Officer??N/AN/AN/A
Dr. John J. Boniface Ph.D.Chief Scientific Officer386.69kN/A1962
Mr. Robert G. HarrisonChief Information Officer384.18kN/A1966
Mr. Benjamin G. Jackson J.D.General Counsel410.75kN/A1979
Dr. Paul Kearney Ph.D.Chief Data OfficerN/AN/A1968
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Corporate governance

Sera Prognostics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.